Bytes from AIPLA 8/7/2003

The following are condensed articles featured in the AIPLA Report August 7, 2003. For complete articles, log on to Questioning Hatch/Waxman At an August 1 hearing before the Senate Judiciary Committee, representatives of the Justice Department and the PTO expressed reservations over certain provisions of legislation meant to reform procedures under the Hatch/Waxman Act by which generic drug makers obtain FDA approval to market their products. At the August 1 hearing, Deputy Assistant Attorney General Sheldon Bradshaw for the Justice Department

Return to MVS News and Events

Connect with MVS

Enter your name and email address to recieve the latest news and updates from us and our attorneys.

Subscribe to: MVS Newsletter

Subscribe to: Filewrapper® Blog Updates

  I have read and agree to the terms and conditions of McKee, Voorhees & Sease, P.L.C.